Adjuvant

Adjuvant chemotherapy improves overall survival for pancreatic cancer patients: JAMA Oncology study

The study showed overall survival was significantly longer in patients who received adjuvant chemotherapy after neo-adjuvant chemotherapy followed by surgery, compared to the group of patients that ... read more

Largest study of its kind reveals adjuvant chemotherapy improves overall survival for pancreatic cancer patients

Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for ... read more

Adjuvant Chemotherapy Improves Overall Survival for Pancreatic Cancer Patients

A new study showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for patients. read more

Everolimus Fails Again as Adjuvant Therapy for High-Risk Breast Cancer

A second randomized trial failed to show a benefit of adding everolimus (Afinitor) to adjuvant endocrine therapy for high-risk hormone receptor (HR)-positive/HER2-negative breast cancer. Patients who ... read more

Lilly shares positive Verzenio data as adjuvant early breast cancer therapy

Eli Lilly (Lilly) has shared its latest results from the pivotal phase 3 monarchE trial of Verzenio (abemaciclib) adjuvant in combination with standard endocrine therapy (ET) for patients with high ... read more

Adding Everolimus to Adjuvant ET Does Not Improve Survival in High-Risk HR+/HER2- Breast Cancer

Results of SWOG S1207 demonstrated the effects of adding everolimus to adjuvant endocrine therapy for 1 year in patients with HR+/HER2- breast cancer ... read more

Genetics may identify breast cancer patients who can safely omit radiation therapy after breast-conserving surgery

Patients with invasive breast cancer who had low scores on an investigational gene molecular signature had similar rates of local recurrence whether or not they received adjuvant radiation therapy ... read more

Patients With HR+ Breast Cancer May Safely Pause Endocrine Therapy to Pursue Pregnancy

Findings from the POSITIVE trial suggest that pausing endocrine therapy to pursue pregnancy did not negatively affect outcomes for patients with breast cancer. read more

Pembrolizumab as adjuvant therapy in non-small-cell lung cancer

In The Lancet Oncology, Mary O’Brien and colleagues1 concluded from the results of the PEARLS/KEYNOTE-091 trial that adjuvant pembrolizumab significantly improved disease-free survival compared with ... read more

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data for its breast cancer radiation signature, Profile for ... read more